View Author
cancer patient breast tumor breast cancer level expression protein study analysis tamoxifen response therapy factor treatment status prognostic receptor survival value table disease model tissue association breast cancer patients adjuvant month twist chemotherapy resistance mutation plasminogen multivariate tamoxifen therapy result prognostic value prognosis sample tamoxifen treatment activator article group allele method multivariate analysis estrogen breast tumors lymph analyses urokinase-type plasminogen activator ratio inhibitor outcome ezh 2 bcar 1 base model menopausal status carcinoma tumor characteristics first-line signi prognostic factors research number system dc-script growth pmn-e hormone tumor size activity pai -2 expression levels signi ficantly point correlation univariate relationship marker
10 Most Recent Publications
|
KLF6-SV1 Drives Breast Cancer Metastasis and Is Associated with Poor Survival
(Article)
Hatami, R. Sieuwerts, A.M. Germain, D.P. Burstein, D. Kirschenbaum, A. DiFeo, A. Foekens, J.A. Narla, G. Izadmehr, S. Yao, Z. Qiao, R.F. Papa, L. Look, M.P. Smid, M. Ohlssen, J. Levine, A.C. |
2013-01-23
|
|
High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes
(Article)
Riaz, M. Sieuwerts, A.M. Look, M.P. Timmermans, A.M. Smid, M. Foekens, J.A. Martens, J.W.M. |
2012-09-11
|
|
Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes
(Article)
Riaz, M. Berns, P.M.J.J. Foekens, J.A. Martens, J.W.M. Sieuwerts, A.M. Ruigrok-Ritstier, K. Weerd, V. de Groenewoud, A. Uitterlinden, A.G. Look, M.P. Klijn, J.G.M. Sleijfer, S. |
2011-07-12
|
|
Prevalence of the variant allele rs61764370 T>G in the 3′UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families
(Article)
Hollestelle, A. Pelletier, C. Aulchenko, Y.S. Martens, J.W.M. Ouweland, A.M.W. van den Weidhaas, J. Hooning, M. Crepin, E. Schutte, A.E.M. Look, M.P. Collée, J.M. Nieuwlaat, A. Dorssers, L.C.J. Seynaeve, C.M. |
2011-07-01
|
|
Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: An independent retrospective validation study
(Article)
Sieuwerts, A.M. Ansems, M. Look, M.P. Span, P.N. Weerd, V. de Galen, A. van Foekens, J.A. Adema, G.J. Martens, J.W.M. |
2010-12-01
|
|
Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer
(Article)
Reijm, E.A. Jansen, M.P.H.M. Ruigrok-Ritstier, K. Staveren, I.L. van Look, M.P. Meijer van Gelder, M.E. Sieuwerts, A.M. Sleijfer, S. Foekens, J.A. Berns, P.M.J.J. |
2010-01-01
|
|
Identification of a putative protein-profile associating with tamoxifen therapy-resistance in breast cancer
(Article)
Umar, A. Martens, J.W.M. Foekens, J.A. Paša-Tolić, L. Kang, H. Timmermans, A.M. Look, M.P. Meijer van Gelder, M.E. Jaitly, N. Bakker, M.A. den |
2009-06-08
|
|
Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response
(Article)
Helleman, J. Jansen, M.P.H.M. Berns, P.M.J.J. Ruigrok-Ritstier, K. Staveren, I.L. van Look, M.P. Meijer van Gelder, M.E. Sieuwerts, A.M. Klijn, J.G.M. Sleijfer, S. Foekens, J.A. |
2008-09-01
|
|
Polymorphic variations in exon 10 of the luteinizing hormone receptor: Functional consequences and associations with breast cancer
(Article)
Piersma, D. Verhoef-Post, M. Look, M.P. Uitterlinden, A.G. Pols, H.A.P. Berns, P.M.J.J. Themmen, A.P.N. |
2007-09-30
|
|
GnRH and LHR gene variants predict adverse outcome in premenopausal breast cancer patients
(Article)
Piersma, D. Themmen, A.P.N. Look, M.P. Klijn, J.G.M. Foekens, J.A. Uitterlinden, A.G. Pols, H.A.P. Berns, P.M.J.J. |
2007-08-10
|
